Company Directory > Diagnostics > International Agency for Research on Cancer (IARC)
The International Agency for Research on Cancer (IARC) is the specialized cancer research agency of the World Health Organization (WHO). Established in 1965, its primary mission is to coordinate and conduct research on the causes of human cancer and the mechanisms of carcinogenesis, as well as to develop scientific strategies for cancer control. The agency is interdisciplinary, bringing together expertise in epidemiology, laboratory sciences, and biostatistics to identify environmental and lifestyle risk factors. IARC is globally recognized for its 'IARC Monographs' program, which evaluates the carcinogenic risk of various agents, including chemicals, complex mixtures, occupational exposures, and lifestyle factors. It also maintains the Global Cancer Observatory (GCO), providing definitive statistics on cancer incidence and mortality worldwide (GLOBOCAN). While it does not develop or commercialize drugs, its research and classifications significantly influence global regulatory policies, pharmaceutical safety assessments, and public health legislation.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Oncology Research & Public Health
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:1965
Ownership:government
Status:operating
FUNDING
Total Raised:$52M
Investors:United States National Institutes of Health (NIH), French National Cancer Institute (INCa), European Commission, Bill & Melinda Gates Foundation, Cancer Research UK, World Cancer Research Fund International
PIPELINE
Modalities:Epidemiological studies, Biomarker discovery, Genomics, Biobanking
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:World Health Organization (WHO)
Key Partnerships:Union for International Cancer Control (UICC) - Global Initiative for Cancer Registries, Bill & Melinda Gates Foundation - HPV vaccine effectiveness evaluations, National Cancer Institute (NCI) - Collaborative research on cancer etiology, European Commission - Joint research on environmental carcinogens
COMPETITION
Position:Leader
Competitors:National Cancer Institute (NCI), American Cancer Society (ACS), German Cancer Research Center (DKFZ), European Academy of Cancer Sciences
LEADERSHIP
Key Executives:
Dr. Elisabete Weiderpass - Director
Scientific Founders:Yves Poggioli, Charles de Gaulle
Board Members:Dr. Tedros Adhanom Ghebreyesus (WHO Director-General), Professor Dorothy Keefe (Chairperson, Governing Council), Dr. Sirpa Heinävaara (Chairperson, Scientific Council)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with International Agency for Research on Cancer (IARC). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.